Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
Pharmalot
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Winners and Losers: Who had a good week — and who didn’t

  • Meghana Keshavan

By Meghana Keshavan Dec. 30, 2016

Reprints
drugs
Alex Hogan/STAT

Each Friday, we list the week’s winners and losers in the biopharmaceutical industry. Here are a few, as of mid-day.

But we wouldn’t be surprised if we saw some more by day’s end: Market close on the Friday before New Year’s is a perfect time for drug makers to slip news under the radar that they’d like to keep quiet.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Tags

Name the much-criticized federal program that has saved the…
Name the much-criticized federal program that has saved the U.S. $2.3 trillion. Hint: it starts with…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Experts debate: Do we need tougher regulation of dietary…
Experts debate: Do we need tougher regulation of dietary supplements?
European Union drug pricing proposal for the pandemic treaty…
European Union drug pricing proposal for the pandemic treaty generates pushback
Inflation caused a sizable drop in net drug prices…
Inflation caused a sizable drop in net drug prices in late 2022, analysis finds
FDA report details problems at Global Pharma plant involved…
FDA report details problems at Global Pharma plant involved in eye drop recall

Recommended Stories